You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Novel Coverglass System with Enhanced Radiation Resistance
SBC: Infoscitex Corporation Topic: AF04029The Foster-Miller team is developing a novel coverglass system that protects photovoltaic cells on space power systems that are exposed to high doses of ionizing radiation. The spectrum of radiation a solar cell is exposed to not only provides usable energy, over time it also reduces the efficiency of the cell by darkening the barrier coverglass, escalates the operating temperature, and deteriora ...
SBIR Phase II 2005 Department of DefenseAir Force -
Bayesian Troop-Target Detection, Tracking, and Prediction Using FOPEN-GMTI Radar
SBC: SCIENTIFIC SYSTEMS CO INC Topic: SB041024The "troop-target" problem of automatic detection, tracking, and prediction of the formations of dismounted ground troops concealed in foliage, using FOPEN-GMTI radars introduces challenges well beyond those encountered in more conventional group-target problems. AD HOC troop formations are considerably more amorphous and unpredictable and they must be deduced from the constituent individuals. Y ...
SBIR Phase II 2005 Department of DefenseDefense Advanced Research Projects Agency -
Microfluidic DNA Sequencing
SBC: GNUBIO, INC. Topic: NHGRIDESCRIPTION (provided by applicant): This is a Phase II SBIR proposal to increase the throughput of our DNA sequencing instrument to enable whole genome sequencing with high efficiency and accuracy for a cost of under 1000 per genome. In Phase I, we developed a working sequencing assay, a microfluidic platform and camera system, and analysis methodology that enable genome alignment and variant ca ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Rapid Clinical Surge-Testing for Biothreat Agents
SBC: FIRST LIGHT BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): Following a bioterrorist attack, hundreds of thousands of potential victims may require testing and treatment. The critical need to test large numbers of people for exposure to a biothreat agent may overwhelm the capacity of the clinical and public health infrastructure. The approximately 25,000 sentinel laboratories in the Laboratory Response Network, which co ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
SBC: IMMUNETICS, INC. Topic: NHLBIThis project is aimed at the development of an enzyme immunoassay (ELISA) for screening blood for antibodies to Babesia microti. Human babesiosis is a malaria-like illness due to infection of red blood cells by various species of protozoan parasites belonging to the genus Babesia. Most human infections reported in the United States are caused by B. microti which is endemic in parts of the northeas ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Development of an anti-malaria toxin vaccine candidate
SBC: ANCORA PHARMACEUTICALS, INC. Topic: N/ADESCRIPTION (provided by applicant): Malarial disease represents one of the most pressing medical healthcare issues facing the world today. While limited drug treatment options exist, a vaccine solution is widely considered as one of the most effective therapeutic weapons to combat malaria. Despite years of research, though, malarial vaccine initiatives have yet to produce a viable candidate. One ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
ChNKG2D-Targeted Cellular Cancer Therapy: Phase I Clinical Trial
SBC: CELDARA MEDICAL, LLC Topic: NHLBIDESCRIPTION (provided by applicant): The global burden of cancer doubled between 1975 and 2000. Cancer became the leading cause of death worldwide in 2010, and is projected to double again by 2020 and to triple by 2030. This horrible disease has touched each of us, and despite enormous investments in prevention and treatment, its impact continues to accelerate. Ideally, any cancer therapy should ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
High Field Magnets for MRI Applications
SBC: Supercon, Inc. Topic: N/ADESCRIPTION (provided by applicant): The specific aim of the Phase I and Phase II research program will be to design and build an "open", split pair coil, high field (>1 .5T), cryogen-free MRI magnet. The key innovation that will make this goal feasible is the development of an advanced, high performance, round high temperature superconductor capable of operation at 20 Kelvin. Operating at a te ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Spectral imaging for automated malignant blast counting
SBC: CAMBRIDGE RESEARCH AND INSTRUMENTATION Topic: N/ADESCRIPTION (provided by applicant): We propose to extend our successful development of an agile spectral light source for light microscopy, funded through the NCI-IMAT initiative, into FDA trials. The SpectraLamp(tm) device enables the automated and quantitative analysis of double-immunostained samples in brightfield (non-fluorescence-based) microscopy, with particular utility for hematopatho ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
A Rapid Point-of-care Diagnostic for C. trachomatis STDs
SBC: NetBio, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): Improved diagnosis of Chlamydia trachomatis (Ct) infections represents a critical unmet medical need. Ct is the most common cause of bacterial sexually transmitted diseases (STD) worldwide, and the Centers for Disease Control and Prevention estimate that there are 2.8 million US cases annually. Currently, 40% of women with untreated infection will develop pelvi ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health